№ files_lp_3_process_7_046380
File format: docx
Character count: 113137
File size: 429 KB
This is a supplementary guideline that updates and expands the Clinical Pharmacogenetics Implementation Consortium (CPIC) recommendations for medication use in patients with G6PD deficiency, incorporating new evidence on drug safety and genetic testing.
Year:
2021
Region / City:
Global
Topic:
Pharmacogenetics, Medication Safety
Document Type:
Supplementary Guideline
Institution:
Clinical Pharmacogenetics Implementation Consortium (CPIC)
Authors:
Roseann S. Gammal, Munir Pirmohamed, Andrew A. Somogyi, Sarah A. Morris, Christine M. Formea, Amanda L. Elchynski, Kazeem A. Oshikoya, Howard L. McLeod, Cyrine E. Haidar, Michelle Whirl-Carrillo, Teri E. Klein, Kelly E. Caudle, Mary V. Relling
Target Audience:
Healthcare providers, Pharmacologists
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Last Update:
September 2021
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2014
Location:
Karachi, Pakistan
Topic:
Medical research, hematology, enzymopathy
Document type:
Research article
Institution:
Dow Institute of Medical Technology, Dow University of Health Sciences; Institute of Molecular Biology and Biotechnology, University of Lahore
Authors:
Umme-Hani, Zumar Hafeez, Muzammal Mateen Azhar, Aamer Mahmood Qazi, Nida Baig
Population:
Male children aged 0–7 years
Sample size:
100
Methodology:
Cross-sectional hospital-based study, Dye Decolorization method for G6PD screening
Key findings:
9% prevalence of G6PD deficiency, mean age 3.6 years, mean hemoglobin 6.8 mg/dL
Publication:
N Y Sci J 2019;12(3):1-3
ISSN:
1554-0200 (print), 2375-723X (online)
DOI:
10.7537/marsnys120319.01
Keywords:
Glucose-6-phosphate dehydrogenase, X-linked, hemizygous, oxidative stress, anemia
Year:
2020
Region / City:
Leeds, UK
Subject:
Hematology / G6PD Testing
Document Type:
Laboratory Referral Form
Institution:
Centre for Laboratory Medicine, SJUH
Author:
Blood Sciences Department
Intended Audience:
Healthcare professionals submitting patient samples
Specimen Requirements:
1 x Fresh EDTA patient sample (3ml minimum) and 1 x anonymised EDTA travel control (1ml minimum)
Parameters Measured:
Hb, WBC, Reticulocytes, MCH, RBC, Platelets
Guidelines Compliance:
BSH Guidelines 2020
Form Version:
Qpulse Code BSHC-FOR-178 v 1.2
Year:
2026
Region / city:
USA, Finland, Sweden, UK
Topic:
Pharmacogenetics, Statins, Musculoskeletal symptoms
Document Type:
Guideline
Organization / Institution:
Clinical Pharmacogenetics Implementation Consortium (CPIC)
Author:
Rhonda Cooper-DeHoff, Mikko Niemi, Laura B. Ramsey, Jasmine A. Luzum, E. Katriina Tarkiainen, Robert J. Straka, Li Gong, Sony Tuteja, Russell A. Wilke, Mia Wadelius, Eric A. Larson, Dan M. Roden, Teri E. Klein, Sook Wah Yee, Ronald M. Krauss, Richard M. Turner, Latha Palaniappan, Andrea Gaedigk, Kathleen M. Giacomini, Kelly E. Caudle, Deepak Voora
Target Audience:
Healthcare professionals, Researchers
Effective Period:
Ongoing
Approval Date:
2026
Modification Date:
2026
Year:
2026
Region / City:
Global
Topic:
Pharmacogenetics, Antidepressants
Document Type:
Guideline
Organization / Institution:
Clinical Pharmacogenetics Implementation Consortium (CPIC)
Authors:
Chad A. Bousman, James M. Stevenson, Laura B. Ramsey, Katrin Sangkuhl, J. Kevin Hicks, Jeffrey R. Strawn, Ajeet B. Singh, Gualberto Ruaño, Daniel J. Mueller, Evangelia Eirini Tsermpini, Jacob T. Brown, Gillian C. Bell, J. Steven Leeder, Andrea Gaedigk, Stuart A. Scott, Teri E. Klein, Kelly E. Caudle, Jeffrey R. Bishop
Target Audience:
Healthcare professionals, geneticists, pharmacologists
Effective Period:
Ongoing
Approval Date:
2026
Modification Date:
Not specified
Year:
2022
Region / City:
N/A
Topic:
Fellowship applications, registration deadlines, pharmacogenetics course
Document Type:
Application form
Organization:
ESHG (European Society of Human Genetics)
Author:
N/A
Target Audience:
Young scientists, students, PostDocs, residents in training
Period of validity:
2022
Approval Date:
N/A
Amendment Date:
N/A
Year:
2023
Region / Location:
Global aquaculture, with examples from East Africa, Asia, Australia, Gulf of California
Subject:
Aquatic animal health, viral diseases in shrimp
Document type:
Scientific/technical chapter
Organization / Authority:
World Organisation for Animal Health (WOAH)
Pathogen:
Yellow head virus genotype 1 (YHV1)
Host species:
Penaeus monodon, Penaeus stylirostris, Penaeus vannamei, Metapenaeus affinis, Palaemonetes pugio, and other susceptible and partially susceptible species
Infection routes:
Direct infection, experimental exposure, contaminated aquaculture products
Viral characteristics:
Enveloped rod-shaped virions, positive-sense single-stranded RNA genome, structural proteins p20, gp64, gp116
Clinical signs:
Yellowish discoloration of cephalothorax, bleached appearance, abnormal feeding behavior, high mortality in juveniles
Transmission:
No known vectors; waterborne survival up to 72 hours
Detection methods:
Transmission electron microscopy, molecular methods (PCR, RT-PCR)
References:
Chantanachookin et al., 1993; Lightner, 1996; Walker et al., 2001; Dong et al., 2017
Year:
2023
Region / City:
United States
Topic:
Genomics, Genetics
Document Type:
Research Paper
Organization / Institution:
Rutgers University, NIH
Author:
Matteo Di Vincenzo, Thanavadee Prachason, Gaia Sampogna, Angelo Arias-Magnasco, Bochao Danae Lin, Lotta-Katrin Pries, Jim van Os, Bart P.F. Rutten, Ran Barzilay, Andrea Fiorillo, Sinan Guloksuz
Target Audience:
Researchers, Geneticists, Biologists
Period of Activity:
2023
Date of Approval:
N/A
Date of Changes:
N/A
Year:
2026
Study type:
Genetic association study
Subjects:
Kidney transplant recipients and donors
Genes analyzed:
CASP1, IL1B, IL10, TLR2, TLR4, BDNF, CRP, IL2, IL6, IL6R, LY96, MYD88, OPRM1, TGFB, TNF
Sample size:
153–154 recipients, 80–84 donors
Measurements:
Diplotypes, haplotypes, genotypes, BPAR incidence
SNPs:
Multiple single nucleotide polymorphisms per gene
Time frame:
First 2 weeks post-transplantation
End point:
Biopsy-proven acute rejection incidence
Data notes:
Percentages may not sum to 100% due to rounding; genotyping failures noted
Year:
2015
Region / city:
Global
Topic:
HPV Genotype and Cervical Intraepithelial Neoplasia
Document Type:
Table
Author:
Monsonego, Vaughan, Wheeler, Schiffman, Naucler, Kitchener, Smelov
Target Audience:
Researchers, Healthcare Professionals
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
N/A
Subject:
Genomic analysis, liver organoids
Document Type:
Research Methodology
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Researchers, genomic scientists
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2024-25
Region / City:
Varanasi, Uttar Pradesh, India
Subject:
Genotype × Environment Interactions, Phenotypic Plasticity
Document Type:
Research Article
Organization / Institution:
ICAR-IIVR
Author:
Choudhary et al.
Target Audience:
Researchers, Plant Breeders
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Keywords:
Brinjal, climate-resilient breeding, genotype × environment interaction, hybrids, inbreds, phenotypic plasticity, seasonal stability
Context:
The document is an academic research article examining genotype by environment interactions in brinjal, focusing on the phenotypic stability and plasticity of qualitative traits across two different seasonal environments.
Year:
2026
Authors:
Didem Pehlivanoglu, Alayna Shoenfelt, Ziad Hakim, Amber Heemskerk, Jialong Zhen, Mario Mosqueda, Robert C. Wilson, Matthew Huentelman, Matthew D. Grilli, Gary Turner, R. Nathan Spreng, Natalie C. Ebner
Corresponding Author:
Didem Pehlivanoglu ([email protected])
Type of Document:
Supplemental research material
Field:
Cognitive neuroscience, behavioral psychology
Study Population:
Adults aged 18–90
Sample Size:
182 participants
Genetic Focus:
APOE genotype, specifically ε2, ε3, ε4 alleles
Research Measures:
S-PEST, PHIT, TICS, OSPAN, BTACT, QAP, self-reported scam victimization
Data Collection Method:
Laboratory and survey-based assessments
Statistical Analyses:
Logistic regression, chi-square tests, interaction analysis
Geographic Context:
Not specified
Supplemental Figures:
S1
Supplemental Tables:
S1
References:
7 cited studies on cognition, genetics, and fraud victimization
Year:
Not specified
Region / city:
Not specified
Theme:
Breast cancer genetics
Document type:
Research figure
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, oncologists
Action period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Context:
A research document presenting the association analysis between YTHDC1 SNPs and breast cancer susceptibility, including figures for SNP analysis and m6A modification prediction.